Compassionate Use Study of Carfilzomib for Patients With Relapsing or Resistant Multiple Myeloma

Trial Profile

Compassionate Use Study of Carfilzomib for Patients With Relapsing or Resistant Multiple Myeloma

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 28 Oct 2015

At a glance

  • Drugs Carfilzomib (Primary)
  • Indications Multiple myeloma
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 23 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 23 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
    • 23 Mar 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top